Ilfat Rakhmatullin

Ilfat Rakhmatullin


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2022 in Petroleum Research
Verified
Journal Article
Open access
IRIlfat Rakhmatullin
Ilfat Rakhmatullin
Sergey V. EfimovSergey V. Efimov
Sergey V. Efimov
AKAlexander V. Klochkov
Alexander V. Klochkov
OGOleg I. Gnezdilov
Oleg I. Gnezdilov
Mikhail A. VarfolomeevMikhail A. Varfolomeev
Mikhail A. Varfolomeev
VKVladimir V. Klochkov
Vladimir V. Klochkov

12 May 2022 in Bioengineering
Verified
Journal Article
Open access
PDF file
GGGalina Guseva
Galina Guseva
Elena V. AntinaElena V. Antina
Elena V. Antina
MBMikhail B. Berezin
Mikhail B. Berezin
ASAnastassia S. Smirnova
Anastassia S. Smirnova
RPRoman Pavelyev
Roman Pavelyev
Sergei BoichukSergei Boichuk
Sergei Boichuk
This paper presents the design and a comparative analysis of the structural and solvation factors on the spectral and biological properties of the BODIPY biomarker with a thioterpene fragment. Covalent binding of the thioterpene moiety to the butanoic acid residue of meso-substituted BODIPY was carried out to find out the membranotropic effect of conjugate to erythrocytes, and to assess the possibilities of its practical application in bioimaging. The molecular structure of the conjugate was confirmed via X-ray, UV/vis-, NMR-, and MS-spectra. It was found that dye demonstrates high photostability and high fluorescence quantum yield (to ~100%) at 514–519 nm. In addition, the marker was shown to effectively penetrate the erythrocytes membrane in the absence of erythrotoxicity. The conjugation of BODIPY with thioterpenoid is an excellent way to increase affinity dyes to biostructures, including blood components.

3 November 2024 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
GGGalina Guseva
Galina Guseva
YEYuliya V. Eremeeva
Yuliya V. Eremeeva
Alexander A. KsenofontovAlexander A. Ksenofontov
Alexander A. Ksenofontov
Elena V. AntinaElena V. Antina
Elena V. Antina
IGIlmir R. Gilfanov
Ilmir R. Gilfanov
Liliya E. NikitinaLiliya E. Nikitina
Liliya E. Nikitina

1 December 2022 in Petroleum Research
Verified
Journal Article
Open access
IRIlfat Rakhmatullin
Ilfat Rakhmatullin
Sergey V. EfimovSergey V. Efimov
Sergey V. Efimov
EKEkaterina I. Kondratyeva
Ekaterina I. Kondratyeva
LGLisset Miquel González
Lisset Miquel González
KSKajum R. Safiullin
Kajum R. Safiullin
VKVladimir V. Klochkov
Vladimir V. Klochkov

19 September 2018 in BioNanoScience
Verified
Journal Article
Closed access
PDF file
IRIlfat Rakhmatullin
Ilfat Rakhmatullin
LGL. F. Galiullina
L. F. Galiullina
ABA. A. Balandina
A. A. Balandina
FKF. K. Karataeva
F. K. Karataeva
YSYurii Shtyrlin
Yurii Shtyrlin
Vladimir KlochkovVladimir Klochkov
Vladimir Klochkov

30 December 2015 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
ILI. A. Latfullin
I. A. Latfullin
LGL. F. Galiullina
L. F. Galiullina
IRIlfat Rakhmatullin
Ilfat Rakhmatullin
VKV. V. Klochkov
V. V. Klochkov
AAArray V. Aganov
Array V. Aganov
A hypothesis that possible pleiotropic features of different statins could be explained by distinctions in their interaction with cell membrane is suggested. Molecular complexes of pravastatin and simvastatin with model of cell membrane were studied by method of nuclear magnetic resonance spectroscopy. It was shown that pravastatin interacts almost exclusively with a surface of cell membrane and, therefore active transport system is needed to deliver pravastatin into the cell. In contrast, simvastatin is located in the inner part of model cell membrane. That’s why it can passively penetrate into organism cells. Perhaps, these differences lead to distinctions of pleiotropic properties of these statins.